Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-04-003030
Filing Date
2004-06-10
Accepted
2004-06-10 16:26:29
Documents
8
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 ALKERMES, INC. b50838aie10vk.htm 10-K 1020178
2 EX-21.1 SUBSIDIARIES OF THE REGISTRANT b50838aiexv21w1.txt EX-21.1 1147
3 EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP. b50838aiexv23w1.txt EX-23.1 697
4 EX-23.2 CONSENT OF ERNST & YOUNG LLP b50838aiexv23w2.txt EX-23.2 788
5 EX-23.3 NOTICE RE: CONSENT OF ARTHUR ANDERSEN LLP b50838aiexv23w3.txt EX-23.3 3469
6 EX-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION b50838aiexv31w1.txt EX-31.1 3552
7 EX-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION b50838aiexv31w2.txt EX-31.2 3544
8 EX-32.1 SECTION 906 CERTIFICATION b50838aiexv32w1.txt EX-32.1 1296
  Complete submission text file 0000950135-04-003030.txt   1037078
Mailing Address
Business Address 88 SIDNEY ST CAMBRIDGE MA 02139-4136 617-494-0171
ALKERMES INC (Filer) CIK: 0000874663 (see all company filings)

EIN.: 232472830 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-14131 | Film No.: 04858587
SIC: 2834 Pharmaceutical Preparations